Manufacturer record
Omnison Pharma (P) Ltd. G-456 & 457: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Omnison Pharma (P) Ltd. G-456 & 457 was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OT-13158, Ibuprofen & Paracetamol Tablets (exp May 2028). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to standard, in respect of Uniformity of Dispersion. Listed in the September 2026 alert.
Records by type
1 record linked to Omnison Pharma (P) Ltd. G-456 & 457 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen & Paracetamol Tablets | Batch OT-13158Mfg Jun 2026 · Exp May 2028 | The sample does not conform to standard, in respect of Uniformity of Dispersion.Uniformity of weight/content | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.